中国医疗保健国际交流促进会胸部肿瘤分会常委/秘书长，
国际肺癌联合会（IASLC）事业发展委员会委员，
中国临床肿瘤协会（CSCO）非小细胞肺癌专业委员会常务委员，
中国临床肿瘤协会（CSCO）青年委员会常务委员，
中国临床肿瘤协会（CSCO）免疫委员会委员，
中国老年医学学会肿瘤分会第一界委员会常务委员，
上海市抗癌协会肿瘤呼吸内镜学专业委员会常务委员，
宋庆龄基金会肿瘤产学研联盟疑难肿瘤专业委员会委员，
担任专业领域知名SCI期刊Annals of Oncology,Journal of Thoracic Oncology，International Journal of Cancer，Lung Cancer等杂志审稿人
Senior Committee/Secretary-General of Chest Cancer Branchof China International Exchange and Promotive Association for Medical andHealth Care（CPAM）
Member of the Career Development Committee of TheInternational Association for the Study of Lung Cancer (IASLC)
Senior Committee Member of the Non small cell lung cancerCommittee of the Chinese Society of Clinical Oncology（CSCO）
Senior Committee Member of the Youth Committee of the ChineseSociety of Clinical Oncology（CSCO）
Member of the Immunity Committee of the Chinese Society ofClinical Oncology (CSCO)
Senior Committee Member of the Oncology Branch of the ChineseGeriatrics Society（CGS）
Senior Committee Member of theRespiratory Endoscopic Branch of Shanghai Anti-Cancer Association
Member of the ProfessionalCommittee on Difficult and Complicated Oncology of Oncology Industry-University-ResearchAlliance of China Soong Ching Ling Foundation
Invitedreviewers of well-acknowledged journals of lung cancer, such as Annals ofOncology, Journal of Thoracic Oncology，International Journal of Cancer，Lung Cancer，etc.
获得 “IASLC fellowship award”、“上海曙光计划”、“上海市人才发展基金” “上海市卫计委优秀青年人才”等多项人才项目资助, 主持国家级课题3项、省部级课题5项，累计科研经费300余万元。近5年作为主要负责人及参与人，先后获得上海市科技进步奖省部级等一等奖4项。已发表论文140余篇，其中发表第一作者或通讯作者SCI论文近40篇，累计影响因子达200分以上。国内国际交流发言100余次，国际大会发言20余次，多次受邀至WCLC，ESMO-Asia, CGLCF等国际会议进行报道发言。长期从事肺癌的早期诊断和肺癌精准化治疗相关的临床和转化研究，并取得了一系列原创性成果，在全国范围内进行推广应用，显著提高了早期肺癌诊断敏感性，极大的延长了晚期肺癌患者的生存时间，对患者的生活质量带来了明显改善。
Hegot a series of grants sponsored by IASLC, Shanghai Shuguang Program,Development Fund for Shanghai talents, Excellent Young Talents Projects of ShanghaiMunicipal Health Planning Commission, and NSFC and Shanghai Municipal Scienceand Technology Commission, etc., with accumulative research fund exceeding 3million RMB. He also has received a series of awards and honors as chiefmanager or participant, such as Second Prize of Shanghai Medical Science andTechnology Award in 2013, Second Prize of Chinese Medical Science andTechnology Award in 2014, First Prize of Chinese Medical Science and TechnologyAward in 2014, Second Prize of Shanghai Anti-cancer Science and TechnologyAward in 2017, First Prize of Science and Technology Award of China Anti-CancerAssociation in 2018 and Shanghai Science and Technology Award First Prize forScientific and Technological Progress in 2019, etc. He has published over 140papers on SCI journals, including about 40 as first or corresponding authorwith accumulative impact factor exceeding 200. He also has been invited aspresenter for international academic conferences, such as WCLC, ESMO-Asia, and CGLCFand also hundreds of domestic academic conferences. He has been engaged inclinical and translational research of early detection and precision medicineof lung cancer, and has achieved a series of original results, which has beenpublished and presented in well-acknowledged journals and meetings, also has beenapplied in multiple hospitals across China and thus greatly augmented thedetection rate of early stage lung cancer, prolonged the survival of patientswith advanced lung cancer, and improved their quality of life.
